Products with Anti-platelet aggregation bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN4096 | Darutigenol |
| 1. Darutigenol has obvious antithrombotic effect,its mechanism may be related to inhibition of platelet aggregation and adhesion. | |
| BCN4129 | Ferulamide |
| 1. Ferulamide derivatives show potent inhibitory activity against arachidonic acid-induced platelet aggregation. | |
| BCN4168 | Morusinol |
| Morusinol may significantly inhibit arterial thrombosis in vivo due to antiplatelet activity, may exert beneficial effects on transient ischemic attacks or stroke via the modulation of platelet activation. | |
| BCN4248 | 6-Acetyl-2,2-dimethylchroman-4-one |
| 1. 6-Acetyl-2,2-dimethylchroman-4-one and vanillin show anti-platelet aggregation activity induced by arachidonic acid in vitro. | |
| BCN4368 | Triacetonamine |
| Triacetonamine protects the activitis of superoxide dismutase(SOD) and creatine phos-phate kinase (CPK); it also inhibits CaCl2 induced agglomeration of thromocyte. Triacetonamine can improve the constructile function of heart mus-cles of acute anemia and decrease the content of malodialdehyde (MDA) in the heart muscles. | |
